蛇毒的抗癌抑癌作用

蛇毒的抗癌抑癌作用阳灵广邮政编码;６２９０００蛇毒是生物毒素之一种。我国的蛇类资源十分丰富,有毒蛇近５０种,常见的剧毒蛇有１０种。经多种试验研究表明：以眼镜王蛇、眼镜蛇、金环蛇、蝮蛇和银环蛇等蛇毒,具有明显的抗癌瘤作用。蛇毒及细胞毒,在体外有明显的杀...     

蛇毒制剂抗肿瘤活性和机理的研究进展

该文简要综述了蛇毒制剂抗肿瘤活性及其机理。实验已证实 ,眼镜蛇、金环蛇、银环蛇等蛇毒对多株人肿瘤细胞系有杀伤和抑制作用 ,其中以眼镜蛇毒对肿瘤细胞的杀伤作用最强。从蛇毒中可分离出心脏毒素、直接溶解因子、细胞毒素 (CT)、神经毒素 (NTX) ,其中 CT是作用较强的成分。这些毒素毒性都通过破坏细胞膜而实现 ,故称为膜毒素。蛇毒在体内外都有抗癌作用 ,对人高、低分化鼻咽癌细胞株 ,人慢性骨髓性白血病和小鼠肝癌均有明显的细胞毒作用 ,其半数抑制浓度 (IC50 )分别为 79μg/ ml、75μg/ ml、5.5μg/ ml、65μg/ ml,表明对白血病最…     

中国的毒蛇和抗蛇毒血清

我国产有近五十种毒蛇中,具有剧毒且对人畜危害较大者,约有十几种,即银环蛇,眼镜蛇,金环蛇,眼镜王蛇,蝰蛇,蝮蛇,尖吻蝮,竹叶青,烙铁头蛇及常见的几种海蛇。我国抗蛇毒血清的研制,一直未得到应有的重视,及至1970年始有抗蛇毒血清供临床使用。目前计有四种产品,即精制抗蝮蛇毒血清,精制抗尖吻蝮蛇毒血清,精制抗银环蛇毒血清和精制抗眼镜蛇毒血清。现正陆续研制抗蝰蛇毒血清,抗金环蛇毒血清等,为治疗我国毒蛇咬伤中毒患者提供可靠的特效药。     

广西眼镜蛇、银环蛇和五步蛇蛇毒的 体外抑菌作用

目的初步研究广西眼镜蛇、银环蛇和五步蛇蛇毒的体外抑菌作用,并比较各种蛇毒对金黄色葡萄球菌、甲型溶血性链球菌、大肠埃希菌和枯草芽胞杆菌的抑菌效果。方法观测4种菌的生长情况。采用微量肉汤稀释法检测广西眼镜蛇、银环蛇和五步蛇蛇毒对4种细菌的抑菌作用,分析比较不同蛇毒的抑菌效果和孵育时间对抑菌效果的影响。结果广西眼镜蛇和五步蛇蛇毒对金黄色葡萄球菌、甲型溶血性链球菌、大肠埃希菌和枯草芽胞杆菌均有一定的抑制作用,而银环蛇蛇毒未见明显抑制作用(1 280μg/mL)。广西眼镜蛇和五步蛇蛇毒对于4种菌孵育48、72 h的MIC_(80)、MIC_(50)值均比孵育24 h提高2倍或以上。金黄色葡萄球菌、大肠埃希菌和枯草芽胞杆菌的抑菌效果:广西眼镜蛇蛇毒五步蛇蛇毒银环蛇蛇毒;甲型溶血性链球菌的抑菌效果:五步蛇蛇毒广西眼镜蛇蛇毒银环蛇蛇毒。结论广西眼镜蛇和五步蛇蛇毒均具有一定的体外抑菌作用,且对于不同种类的细菌抑菌活性不同,银环蛇蛇毒未发现有明显的体外抑菌作用。     

实验证明三种蛇毒有抗癌作用

中国科学院昆明动物研究所的研究人员近年来将眼镜蜿科的蛇毒对腹水癌细胞的作用进行研究,经过动物体外试验、体内试验和接种率试验观察发现,眼镜王蛇毒、眼镜蛇毒、金环蛇毒有抗癌作用,其中以眼镜王蛇毒、金环蛇毒和金环蛇毒细胞毒素抗癌作用最强,     

蛇毒与细胞因子研究进展

全世界共有蛇类2500余种,其中毒蛇约650余种,估计每年被毒蛇咬伤的人数在30万以上,死亡率约为10％。我国蛇类有160余种,其中毒蛇约有50余种。剧毒、危害剧大的有10种,如眼镜蛇王、金环蛇、眼镜蛇、五步蛇、银环蛇、蝰蛇、蝮蛇、竹叶青、烙铁头、海蛇等,咬伤后能致人于死亡。我国两广地区蛇害严重,每年蛇咬伤的发病率约为25/10000。蛇毒的成分比较复杂．主要由蛋白质、多肽类和多种酶类组成。蛇毒对机体的作用比较复杂,按其有毒成分的毒理作用可分为神经毒、血循环毒和混合毒三类。银环蛇、金环蛇、海蛇的蛇毒主要含神经毒,其主要作用特点为通过多种不同的方式阻断神经一肌肉接头的冲动传递而导致呼吸肌麻痹,是蛇伤致死的主要原因;蝰蛇、五步蛇、烙铁头和竹叶青的蛇毒主要含血循环毒,包括心脏毒、凝血毒、溶血毒、蛋白水解酶、透明质酸酶等;眼镜王蛇等蛇毒属于混合毒,此类蛇毒既含神经毒成分,又含血循环毒成分。     

八种常见国产蛇毒对白血病细胞杀伤作用研究

用体外细胞培养的方法,观察了我国常见的八种蛇毒（眼镜蛇毒、蝮蛇毒、眼镜王蛇毒、竹叶青蛇毒、蝰蛇毒、烙铁头蛇毒、银环蛇毒及金环蛇毒）对人白血病Ｔ淋巴细胞系ＣＥＭ细胞、人单核细胞白血病Ｕ９３７细胞及人早幼粒细胞白血病ＨＬ６Ｏ细胞的生长曲线、存活率及分裂指数的影响。结果发现八种常见蛇毒中眼镜蛇毒对白血病细胞的杀伤作用最强,蝮蛇毒次之（与空白对照组相比,Ｐ值均小于０．０１）,其余六种蛇毒的作用则很弱。但无论是眼镜蛇毒还是蝮蛇毒,其杀伤淋巴细胞白血病、单核细胞白血病及早幼粒细胞白血病细胞的作用之间无显著差异。     

蛇毒的研究和利用 Ⅰ.我国几种常见毒蛇的蛇毒酶活力的测定

本文对我国几种常见的毒蛇,即五步蛇、蝮蛇、竹叶青蛇、金环蛇、银环蛇、眼镜王蛇以及4种不同产地的眼镜蛇的蛇毒的12种酶活力进行了测定,报告了各活力的数值并对这些结果进行了讨论。     

青龙蛇药抗蛇毒中毒的实验研究

本文总结对青龙蛇药抗蛇毒中毒作用进行研究的买验结果,经动物实验证明,青龙蛇药口服对眼镜蛇毒、眼镜王蛇毒、五毒蛇毒及蝮蛇毒中毒的小白鼠有明显的保护作用,而对银环蛇毒中毒的保护率很低;还证明该药有对抗蛇毒的出血毒性、溶血毒性、毛细血管损伤及组织坏死的作用。     

我国几种常见毒蛇蛇毒的凝胶等电聚焦电泳

本文报导了用凝胶聚焦电泳方法分离我国常见的蝮蛇、尖吻蝮、蝰蛇、金环蛇、银环蛇、眼镜蛇、眼镜王蛇七种毒蛇蛇毒,它们的电泳区带数分别为34、33、35、26、24、23、23。在操作过程中,凝胶中加入7M尿素,蛇毒样品量500微克,pH3.5—10两性载体(Ampholinc),是获得良好结果的关键。     

Cytotoxic activity of various snake venoms on melanoma, B16F10 and chondrosarcoma

Elapid, crotalid and viperid venoms were screened in vitro and in vivo for cytotoxicity towards B16F10 melanoma and chondrosarcoma cell lines. The cytotoxic activity of elapid venoms was considerably higher than that of viperid or crotalid venoms. Elapid venoms disrupted the cell membrane within the first hour, leading to cell death. The strongest activity was found in the venom of Naja nigricollis. The venoms of some Viperidae and of all Crotalidae examined caused the cells to become rounded, without loss in their original volume, and to form aggregates. These changes were reversible when cells were changed to fresh medium. In vivo experiments with the venom of Naja nigricollis were in total agreement with the results achieved in vitro with melanoma cells and the venom exhibited similar cytotoxic activity on chondrosarcoma, inhibiting its development in vivo.     

金环蛇蛇毒对S180,EAC腹水癌细胞的细胞毒性作用

目的　探讨金环蛇毒对 S1 80 ,EAC腹水癌细胞的细胞毒性作用。　方法　采用小白鼠腹腔和皮下接种 S1 80 ,EAC腹水癌细胞造成小白鼠腹水模型后腹腔注射金环蛇毒。　结果　腹腔注射金环蛇毒 ,能抑制肿瘤细胞的生长 ,降低接种率。但不能完全控制腹水和癌细胞的生长。体外试验表明有明显的细胞毒作用。台酚蓝染色镜检可见死细胞显著增加 ,腹水图片检查给药后细胞膜破裂 ,纤维化坏死明显。　结论　能延长小白鼠存活时间。     

Antitumor effect of Bothrops jararaca venom

Many experimental studies have been carried out using snake venoms for the treatment of animal tumors, with controversial results. While some authors have reported an antitumor effect of treatment with specific snake venom fractions, others have reported no effects after this treatment. The aim of this study was to evaluate the effect of Bothrops jararaca venom (BjV) on Ehrlich ascites tumor (EAT) cells in vivo and in vitro. In the in vivo study, Swiss mice were inoculated with EAT cells by the intraperitoneal (i.p.) route and treated with BjV venom (0.4 mg/kg, i.p.), on the 1st, 4th, 7th, 10th, and 13th days. Mice were evaluated for total and differential cells number on the 2nd, 5th, 8th, 11th and 14th days. The survival time was also evaluated after 60 days of tumor growth. In the in vitro study, EAT and normal peritoneal cells were cultivated in the presence of different BjV concentrations (2.5, 5.0, 10.0, 20.0, 40.0, and 80 microg) and viability was verified after 3, 6, 12 and 24 h of cultivation. Results were analyzed statistically by the Kruskal-Wallis and Tukey tests at the 5% level of significance. It was observed that in vivo treatment with BjV induced tumor growth inhibition, increased animal survival time, decreased mortality, increased the influx of polymorphonuclear leukocytes on the early stages of tumor growth, and did not affect the mononuclear cells number. In vitro treatment with BjV produced a dose-dependent toxic effect on EAT and peritoneal cells, with higher effects against peritoneal cells. Taken together, our results demonstrate that BjV has an important antitumor effect. This is the first report showing this in vivo effect for this venom.     

蝮蛇毒抗凝血活酶组份及几种蛇毒粗毒对人红细胞和血小板的作用

蝮蛇毒抗凝血活酶组分及蝗蛇毒、圆斑蝰蛇毒和眼镜蛇毒粗毒,不仅能够水解血浆中的磷脂,而且还能水解完整人红细胞膜和完整人血小板膜上的磷脂。但是五步蛇毒和金环蛇毒粗毒却不能水解完整人血小板膜上的磷脂。 扫描电镜观察表明,由于抗凝血活酶组份和几种蛇毒粗毒的作用,人红细胞和人血小板的形态发生了巨大的变化;人红细胞由正常的双圆盘形变成带刺的小球,人血小板的外形变成蜂窝状。     

Aberrant IgM signaling promotes survival of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand black mice

New Zealand Black (NZB) mice develop a lupus-like syndrome. Although the precise immune defects leading to autoantibody production in these mice have not been characterized, they possess a number of immunologic abnormalities suggesting that B cell tolerance may be defective. In the bone marrow, immature self-reactive B cells that have failed to edit their receptors undergo apoptosis as a consequence of Ig receptor engagement. Splenic transitional T1 B cells are recent bone marrow emigrants that retain these signaling properties, ensuring that B cells recognizing self-Ags expressed only in the periphery are deleted from the naive B cell repertoire. In this study we report that this mechanism of tolerance is defective in NZB mice. We show that NZB T1 B cells are resistant to apoptosis after IgM cross-linking in vitro. Although extensive IgM cross-linking usually leads to deletion of T1 B cells, in NZB T1 B cells we found that it prevents mitochondrial membrane damage, inhibits activation of caspase-3, and promotes cell survival. Increased survival of NZB T1 B cells was associated with aberrant up-regulation of Bcl-2 after Ig receptor engagement. We also show that there is a markedly increased proportion of NZB T1 B cells that express elevated levels of Bcl-2 in vivo and provide evidence that up-regulation of Bcl-2 follows encounter with self-Ag in vivo. Thus, we propose that aberrant cell signaling in NZB T1 B cells leads to the survival of autoreactive B cells, which predisposes NZB mice to the development of autoimmunity.     

用尖吻蝮蛇毒、蝗蛇毒及抗蛇毒血清处理小鼠S_(180)、EAC腹水癌的初步观察

本文报道了尖吻蝮蛇毒、蝮蛇毒及抗蛇毒血清能使接种S_(180)、EAC腹水癌的小鼠明显延长存活时间、降低接种率,但不能完全阻止痛细胞生长。体外具有较明显的导致,菡细胞肿胀、膜破裂,核纤维化,坏死等。从腹水酶活力测定及抗血清初步研究结果表明,癌细胞病变中产生的某些抗原物质可能与蛇毒中的酶和毒蛋白相近。因此注射蛇毒后可在体内产生相关抗体,中和癌细胞产生的毒素以达到治疗目的。     

Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro

Epstein-Barr virus (EBV) establishes latent infections in a significant percentage of the population. Latent membrane protein 2A (LMP2A) is an EBV protein expressed during latency that inhibits B-cell receptor signaling in lymphoblastoid cell lines. In the present study, we have utilized a transgenic mouse system in which LMP2A is expressed in B cells that are specific for hen egg lysozyme (E/HEL-Tg). To determine if LMP2A allows B cells to respond to antigen, E/HEL-Tg mice were immunized with hen egg lysozyme. E/HEL-Tg mice produced antibody in response to antigen, indicating that LMP2A allows B cells to respond to antigen. In addition, E/HEL-Tg mice produced more antibody and an increased percentage of plasma cells after immunization compared to HEL-Tg littermates, suggesting that LMP2A increased the antibody response in vivo. Finally, in vitro studies determined that LMP2A acts directly on the B cell to increase antibody production by augmenting the expansion and survival of the activated B cells, as well as increasing the percentage of plasma cells generated. Taken together, these data suggest that LMP2A enhances, not diminishes, B-cell-specific antibody responses in vivo and in vitro in the E/HEL-Tg system.     

Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination.

Spirochete adaptation in vivo is associated with preferential Borrelia burgdorferi gene expression. In this paper, we show that the administration of B. burgdorferi-immune sera to IFN-gammaR-deficient mice that have been infected with B. burgdorferi N40 for 4 days causes spirochete clearance. In contrast, immune sera-mediated clearance of B. burgdorferi N40 is not apparent in immunocompetent mice, suggesting a role for IFN-gamma-mediated responses in B. burgdorferi N40 host adaptation. B. burgdorferi-immune sera also induces clearance of B. burgdorferi N40 that have been passaged in vitro 75 times (B. burgdorferi N40-75), a derivative of B. burgdorferi N40 that does not rapidly adapt in vivo in immunocompetent mice. B. burgdorferi N40-75 produce lower levels of IFN-gamma and IL-12 in mice than does B. burgdorferi N40, and the administration of these cytokines to B. burgdorferi N40-75-infected mice results in an increased spirochetal burden, further indicating that IFN-gamma-mediated events promote B. burgdorferi survival. Differential immunoscreening and RT-PCR demonstrate that IFN-gamma-mediated signals facilitate spirochete recombination at the variable major protein like sequence locus, a site for early antigenic variation in vivo, and that recombination rates by B. burgdorferi N40 are lower in IFN-gammaR-deficient mice than in control animals. These results suggest that the murine immune response can promote the in vivo adaptation of B. burgdorferi.     

IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production

Persistent cross-linking of hen egg lysozyme (HEL)-specific B cell membrane Ig (mIg) in double transgenic mice that express soluble HEL as a self Ag (HEL-Ig mice) decreases B cell mIgM expression, responsiveness, and life span. Because in vitro treatment with IL-4 inhibits T cell apoptosis through a Stat6-independent mechanism, increases mIg expression, and suppresses activation-induced B cell death, we studied IL-4 effects on B cell mIg expression, survival, and Ab secretion in Stat6-sufficient and deficient HEL-Ig mice. IL-4 treatment nearly normalized B cell number and greatly increased the percentage of mature B cells in HEL-Ig mice, but failed to normalize mIgM expression or spontaneous LPS-induced IgM secretion. IL-4 effects on B cell survival and maturation were CD4(+) T cell independent, but Stat6 dependent, and did not involve receptor editing. IL-4 had to be present while B cells were generated to have a detectable effect on autoreactive B cell survival; however, the survival of B cells generated in the presence of IL-4 was substantially increased even after IL-4 was withdrawn. These observations suggest that: 1) activation-induced B cell death and anergy are independent processes; 2) B cells that survive to maturity develop increased resistance to Ag-induced deletion; and 3) IL-4 promotes B and T cell survival through different mechanisms.     

乌梢蛇血清的抗出血因子:一个有前途的抗蛇毒药物原料

用柱层析和聚丙烯酰胺凝胶盘状电泳法,从乌梢蛇血清中分离纯化了一个抗出血因子。用SDS-聚丙烯酰胺凝胶电泳法测得其分子量大约为65 kD;测定了五种蝮亚科蛇毒(尖吻蝮、竹叶青蛇、原矛头蝮、哈扑和短尾蝮)的最小出血剂量和乌梢蛇血清中抗出血因子对这五种蛇毒的抗出血活性;还测定了七种蛇毒(除上述五种毒蛇外,还包括圆斑蝰和银环蛇)的半数致死量,以及抗出血因子对中毒小鼠的治疗作用。结果显示:从乌梢蛇血清中提纯的抗出血因子的抗蛇毒活性,不仅可以抵抗它的捕食者尖吻蝮的蛇毒,而且还可以抵抗具出血活性的其它蛇毒;但它对不具出血活性的银环蛇毒的致死抑制作用不明显。该抗出血因子不仅在体外实验表现出强的中和出血毒素的活性,而且在体内实验中亦表现出对中毒小鼠良好的治疗作用,因而可能成为新的抗蛇毒药物的有前途的原料。乌梢蛇血清对血循毒的中和能力的获得,可能归因于尖吻蝮与乌梢蛇之间捕食与被捕食相互作用的关系。